institution logo
If you're member of the institution,  you just have to login to download the file in restricted access. It is not necessary to request a print.

Request copy

Une nouveauté dans la prise en charge de l’ostéoporose post-ménopausique à très haut risque fracturaire : le romosozumab (Evenity®), un anticorps monoclonal anti-sclérostine.
Bolland, Meilyn; Malaise, Olivier; Ribbens, Clio
2023In Revue Médicale de Liège, 78 (4), p. 239 - 244

Document(s) requested
12 Vign-Malaise-Osteoporose CV (7) .pdf

The desired document is not currently available on open access. Nevertheless you can request an offprint through the form below. If your request is accepted you will receive by e-mail a link allowing you access to the document for 5 days, 5 download attempts maximum.


Request form

Fields marked with ✱ are compulsory.

Back to the reference
Contact ORBi